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Abstract  35 
 36 
Purpose: This case study of an international rower examines a diagnosis of 37 
Unexplained Under Performance Syndrome (UUPS or Overtraining Syndrome) 38 
describing a full recovery and return to elite competition the same year. Methods: On 39 
diagnosis and 4 and 14 months post-diagnosis, detailed assessments including 40 
physiological, nutritional, and biomarkers were made. Results: Clinical examination 41 
and laboratory results for haematology, biochemistry, thyroid function, immunology, 42 
vitamins and minerals were unremarkable and did not explain the presentation and 43 
diagnosis. Redox biomarkers including hydroperoxides, plasma antioxidant capacity, 44 
red blood cell glutathione, superoxide dismutase, co-enzyme Q10, vitamin E (α and γ-45 
tocopherol), and carotenoids (lutein, α-carotene, β-carotene) provided evidence of 46 
altered redox homeostasis. The recovery strategy began with 12 days of training 47 
abstinence and nutritional interventions, followed by 6-weeks of modified training. 48 
Four months post-intervention performance had recovered strongly, resulting in the 49 
athlete becoming European champion that same year. Further improvements in 50 
physiological and performance indices were observed at 14 months post-intervention. 51 
Physiologically relevant increases in concentrations of carotenoids were achieved at 52 
each post-intervention time point, exceeding the reported critical difference values. 53 
Conclusions: We conclude that increasing athlete phytonutrient intake may enhance 54 
recovery and tolerance to training and environmental stressors, reducing the risk of 55 
unexplained under performance syndrome. Alterations in redox homeostasis should 56 
be considered as part of the medical management in unexplained under performance 57 
syndrome. This is the first reported case study of an elite athlete with  alterations in 58 





Unexplained Under Performance Syndrome (UUPS) [1] describes an athlete 64 
presenting with persistent fatigue in the absence of disease, together with a decline in 65 
performance recognised by coach and athlete. This condition is otherwise known as 66 
overtraining syndrome. [2] However, UUPS reflects the complexity of the condition, 67 
the multi-factorial aetiology, and that imbalances between training load and recovery 68 
may not be the primary reason for the condition. [1]  69 
Exercise is a source of reactive nitrogen and oxygen species (RNOS), leading 70 
to alterations in redox homeostasis (ARH). [3] RNOS are important for adaptation to 71 
training, [4] nonetheless, a critical balance (captured in the theory of hormesis) [5] 72 
exists between the sufficient or “optimum” dose of RNOS to drive adaptation, and the 73 
over-production of RNOS that could lead to apoptosis, immunosuppression, increased 74 
fatigue and impaired performance. Oxidative stress (OS) has been observed in athletes 75 
diagnosed with OTS  [6] and in the context of UUPS and fatigue, it is noteworthy that 76 
psychological stress also increases OS. [7]  77 
Olympic class rowing requires large training volumes, involves a long 78 
competition season with global travel, and the athlete to make weight; all of which 79 
make elite lightweight rowers highly susceptible to UUPS. Some of the largest acute 80 
ARH in elite endurance athletes are reported in rowers in the general preparation 81 
phase. [3] To date no studies have examined ARH in elite athletes diagnosed with 82 
UUPS/OTS.  83 
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 84 
Case study  85 
The athlete is an experienced international female lightweight rower.  She 86 
provided written informed consent for the participation in all investigations and the 87 
publication of her clinical data.  88 
 89 
Medical history, diagnosis, UUPS clinic examination and testing 90 
In the winter general preparation phase, the athlete presented to the Great Britain 91 
(GB) Rowing Team Doctor via her coach for suspected UUPS.  Heightened fatigue, 92 
mood disturbances and a performance decrement that had been evident for several 93 
weeks. The athlete reported feeling disengaged with her training and described 94 
‘simply going through the motions of training’. In addition, she reported not sleeping 95 
well, experiencing disturbing dreams, and becoming emotionally labile. Clinical 96 
examination was unremarkable (mental health and/or eating disorders were excluded); 97 
carried out by the Chief Medical Officer for GB Rowing (A.R.). No acute infection 98 
was reported but the final drop in performance was preceded by a mild viral upper 99 
respiratory tract infection. She reported no regular medication. Nutritional 100 
supplements were taken as part of the GB Rowing Team nutritional program, 101 
consisting of combined carbohydrate and protein, and protein only recovery products, 102 
specific micronutrients, and an electrolyte powder. Clinical laboratory results where 103 
available (see table 1) were unremarkable apart from serum urea and Epstein-Barr 104 
virus (EBV) nuclear antigen, the latter indicative of previous (latent) EBV infection.  105 
 106 
Insert table 1 here 107 
 108 
 109 
Organic disease was excluded and a diagnosis of UUPS was made. A number of 110 
investigations were undertaken: Resting venous blood draws for the analysis of 111 
hydroperoxides (FORT), plasma antioxidant capacity (FORD), lutein, red blood cell 112 
glutathione (RBC GSH), α and γ-tocopherol (see previous methodology [8]): An 113 
incremental exercise test on a rowing ergometer. In order to assess the redox response 114 
to exercise and provide training intensities for recovery, the rowing ergometer test 115 
consisted of two parts: 1) a submaximal discontinuous incremental exercise of 5 x 4 116 
min stages separated by 30s to produce a lactate/heart rate curve. Following a 2.5 min 117 
recovery period, a final 4 min maximal stage was completed, whereby the athlete was 118 
encouraged to provide a maximal effort, recognising that this may not be possible in 119 
the UUPS state. FORD and FORT were assessed following submaximal and maximal 120 
exercise and during recovery.  Finally, a training history, and nutritional and body 121 
composition assessments were undertaken, of which body weight was comparable 122 
across all three visits (±1.0 kg), as were skinfolds (± 3.3mm) measured across 8 sites 123 
by the same technician; accredited via the International Society for the Advancement 124 
of Kinanthropometry. A 5-day written and photographic food diary was analysed 125 
using Nutritics© software (Table 2). Three food diaries were collected; the week 126 
following her UUPS diagnosis; again at 14 months follow up; and a previous winter 127 
training period when healthy via the GB team nutritionist for comparison.   128 
 129 
Insert table 2 here 130 
 131 
 Following completion of her initial physiological and nutritional assessment 132 
and biomarker profiling at diagnosis, a number of dietary interventions were 133 
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instigated to: 1) facilitate rapid recovery and return to training; 2) prevent relapses; 3) 134 
enable improved tolerance of the training load and environmental “stressors”.  The 135 
dietary interventions consisted of dietary protein in the form of un-denatured whey 136 
protein (Immunocal™), increased consumption of dietary antioxidants in the form of 137 
fruits, vegetables and specific nuts and seeds (recognising the aforementioned foods 138 
will also provide proteins, fatty acids, minerals, vitamins and energy), and selective 139 
use of an antioxidant supplement as a concentrated source of anthocyanins and 140 
melatonin; Cherry Active™.   141 
 142 
Physiological testing results 143 
 Positive physiological improvements for sub-maximal and maximal exercise 144 
were evident at 4 and 14 months post-intervention, indicated by lower blood lactate 145 
and heart rate responses for each power output produced (Figure 1).   146 
 147 
Insert figure 1 here 148 
 149 
Training volume and adherence 150 
 Prior to the onset of UUPS, training adherence to winter training comprised 151 
100% of the prescribed training load. On diagnosis, ~12 days of complete rest was 152 
advised. Following which, training was resumed at a reduced volume for 6 weeks, 153 
with heart rate limits imposed on training sessions to avoid further pro-oxidant 154 
stimulus. This was followed by 3.5 weeks of full volume training but utilised alternate 155 
modalities at carefully prescribed intensities; normal training resumed at 10 weeks 156 
post diagnosis.  The period between resuming normal training and winning at the 157 
European Rowing Championships, 100% training adherence was achieved.  158 
 159 
Case discussion 160 
To our knowledge this is the first documented case of UUPS in an elite 161 
endurance athlete, with complete recovery of performance. It is remarkable, that in 162 
the same season as being diagnosed with UUPS and failing to complete planned 163 
winter training, the athlete became European champion. In addition, we present novel 164 
findings of ARH on diagnosis of UUPS and at 4 and 14 months recovery. Moreover, 165 
the ARH, most notably the substantial increases in her blood carotenoids at 4 and 14 166 
months post-intervention are of physiological significance based on published critical 167 
difference values (CDV), which provide confidence in physiologically relevant 168 
biomarker changes. [8] 169 
We believe the athletes’ recovery and increased capacity to tolerate OS most 170 
notably at 4 months post-intervention (biomarkers of OS remaining high i.e. SOD and 171 
FORT) are related to the substantial increases in her serum carotenoid concentrations 172 
(>CDV; see table 3). Our assumptions being supported by the following: 1) Blood 173 
carotenoid concentrations are valid biomarkers of fruit and vegetable consumption, [9] 174 
which were increased via her diet: 2) 2-weeks of reduced fruit and vegetable intake in  175 
athletes results in decreases in blood carotenoid concentrations, increases in OS and 176 
rate of perceived exertion: [10] 3) The observed changes in blood carotenoids are 177 
greater than the reported CDV for the aforementioned biomarkers and therefore of 178 
physiological significance:[8] 4) Carotenoids provide a more robust cellular 179 
antioxidant defence and response to “stress”  through increased scavenging of RNOS 180 
and through activation of signalling pathways leading to increased expression of cyto-181 
protective genes. [11] Starting periods of intensified training with higher concentrations 182 
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of carotenoids could be advantageous when the physiological and psychological stress 183 
is high.  184 
 185 
Insert table 3 here 186 
 187 
The following factors may have collectively caused overwhelming OS leading 188 
to the athlete’s diagnosis of UUPS: 1) Pre- and post- world championship 189 
psychological stress and associated disturbed sleep; 2) increased winter resistance 190 
training load; and 3) upper respiratory tract infection in the week’s prior to UUPS. It 191 
is well understood, that psychological stress, [7] overload resistance training [12] and 192 
infection induce OS. [13] Consequently, chronic OS may have hampered recovery, 193 
inducing a state of excessive fatigue. Indeed, FORT concentrations exceeded those 194 
reported for elite endurance athletes and well trained athletes in the general 195 
preparation phase. [8,14] At 4 months post-diagnosis, FORT concentrations remained 196 
elevated, despite recovery of performance, reflecting on going OS. However we 197 
submit that a greater capacity to tolerate the OS as a result of substantial increases in 198 
the blood carotenoids (and other phytonutrients not otherwise quantified e.g. 199 
polyphenols) and dieta y advice from the diagnosis of UUPS to recovery, served to 200 
protect the athlete through robust cellular defences, enabling her to maintain 100% 201 
adherence to the training programme, and restore elite performance.  202 
The strategy of bolstering phytonutrient intake through increasing the dietary 203 
supply of fruits, vegetables, nuts and seeds appears to have improved antioxidant 204 
defences (nutrients and synthesis of enzymes). We also provided protein in the form 205 
of undenatured whey, reported to increase intracellular GSH and influence physical 206 
performance. [15] In addition, a concentrated source of anthocyanins in the form of 207 
cherries, known to decrease OS. [16] Indeed, the athlete’s dietary analysis provides 208 
additional evidence for the changes in dietary patterns post-intervention.  For example, 209 
her dietary intake of vitamin A and vitamin E were 136% and 90% greater at 14 210 
months post intervention than at diagnosis. Of interest, athletes on a 2-week 211 
antioxidant restricted diet were reported to consume 976 ± 120 vitamin A ug/d; [10] 212 
comparable with her vitamin A intake at diagnosis (table 2). Furthermore, in support 213 
of positive behavioural changes in fruit, vegetables, nuts and seeds leading to 214 
improved recovery, folic acid (339 mg vs. 277mg), vitamin C (149 mg vs. 65 mg), 215 
vitamin E (21 mg vs. 11mg) and fat intakes (121g vs. 72 g) were all greater in 216 
recovery, than at diagnosis.  217 
In conclusion, we provide the first evidence of ARH in an elite international 218 
rower in association with UUPS. Increasing dietary phytonutrient intake in endurance 219 
athletes may enhance recovery from UUPS, and may serve to reduce the future risk of 220 
UUPS. 221 
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Tables  289 
Table 1. Clinical laboratory results and dietary analysis on diagnosis of UUPS and at 290 
4 and 14 months post interventions  291 
Haematology Units Range UUPS 14 months  
RBC 10*12/L 3.80 - 5.00 4.49 4.62 
Haemoglobin g∙L-1 115 – 145 145 145 
Haematocrit L∙L-1 0.360 - 0.460 0.430 0.436 
MCV f∙L-1 84 – 98 96 94 
MCH pg-1 27.5 - 32.0 32.3 31.4 
MCHC g∙L-1 300 - 360 336 333 
RDW % >14.5 13 13 
WBC 10*9∙L-1 3.5 - 10.0 5.51 4.70 
Neutrophils 10*9∙L-1 1.7 - 7.5 3.39 2.20 
Lymphocytes 10*9∙L-1 1.0 - 3.5 1.61 1.80 
Monocytes 10*9∙L-1 0.3 - 1.0 0.41 0.60 
Eosinophils 10*9∙L-1 <0.4 0.07 0.10 
Basophils 10*9∙L-1 <0.1 0.0 0.0 
N/L 10*9∙L-1 < 1.0 2.1 1.2 
Platelets 10*9∙L-1 150 - 400 317 255 
Urea mmol∙L-1 2.5 - 7.8 8.8 9.2 
Creatinine umol∙L-1 20 - 107 70 84 
Creatine Kinase U∙L-1 25 - 320 24 390 
Asparate transferase U∙L-1 1 - 45 28 53 
Alkaline Phosphatase U∙L-1 30 - 130 55 54 
Alanine transferase U∙L-1 1 - 50 28 38 
Gamma glutamyl transferase U∙L-1 1 - 55 14 10 
Total Bilirubin umol∙L-1 1 - 25 4 4 
Sodium mmol∙L-1 133 - 146 142 139 
Potassium mmol∙L-1 3.5 - 5.3 4.1 5.1 
Iron umol∙L-1 10.6-28.3 18   
Total iron binding capacity umol∙L-1 41-77 71   
Ferritin ug∙L-1 25 - 200 36 32 
Transferrin saturation % 20 - 55 26   
Total protein g∙L-1 64 - 83 68   
Albumin g∙L-1 35 - 50  42 38 
C-reactive protein mg·L-1 1 - 10 0.5 0.5 
Erythrocyte sedimentation 
rate mm∙h
-1 1-10 2.0   
Free T3 pmol∙L-1 2.6 - 5.7 4.2 4.3 
Free T4 pmol∙L-1 9.0 - 22.0 19.0 12.7 
TSH mU∙L-1 0.35 - 5.00 2.0 2.3 
EBNA IgG antibody U∙ml-1 0 - 5 397*  
EBV early Ag Ab (IgG) U∙ml-1 0 - 10 <5  
EBV VCA Ab (IgM) U∙ml-1 0 -20 <10  
* results suggestive of past 
(latent) EBV infection 
    
 292 
  293 
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Table 2. Dietary analysis  294 
 295 
 Pre-UUPS  UUPS♯ 14 months 
Energy (Kcal) 3166 1966 3030 
Carbohydrate (g) 432 208 308 
Protein (g) 194 134 179 
Fat (g) 78 72 121 
Vitamin E (mg) 7.2 11.1 21 
Vitamin A* (µg) 711 1060 2509 
Vitamin C (mg) 171 65 149 
Folate (µg) 499 277 339 
    
Vegetable serves per day**  2 2 6 
Fruit serves per day ** 3 1 3 
Nut serves per day** 0 0 1 
Seed serves per day** 1 0 2 
Protein serves per day 
5-6  4-5  6 + 2 serves of 
un-denatured 
whey protein  
*Retinol equivalents; including preformed retinoids from animal foods, and 296 
precursor carotenoids from plant foods. 297 
♯ = food diary taken the week following diagnosis, with the athlete undertaking 298 
prescribed rest, not training or using any protein & carbohydrate supplements. 299 
**median  300 
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change (%)   




UUPS to 14 
months post 
CDV (%) 
FORT 1.22 - 4.56 mmol∙L-1 H2O2 3.01 3.88 1.80 14 -40 17 
FORD 
 0.25 - 3.0 mmol ∙ L-1 
Trolox 
1.69 1.45 1.86 -29 10 24 
Co-enzyme Q10  0.55 - 2.0 umol∙L-1 0.57 0.51 0.93 -11 63 * 
RBC SOD 1102 - 1601 U∙gHb-1 1923 1933 1416 <1 -26 * 
RBC GSH 1.6 - 2.8 mmol∙L-1  2.15 1.89 2.21 -12 3 24 
α-tocopherol  25 - 60 mmol∙L-1 30.0 24.0 26.0 -20 -13 14 
γ-tocopherol 2.0 - 8.5 umol∙L-1 1.60 2.08 1.79 30 12 37 
α-carotene 0.3 - 1.5 umol∙L-1 0.20 1.20 0.46 500 130 107 
β-carotene 0.4 - 3.0 umol∙L-1 0.52 3.69 1.90 609 265 28 
Lutein 0.4 - 1.10 umol∙L-1 0.52 1.04 0.94 100 81 13 
Total 
carotenoids 
No range umol∙L-1 1.24 5.93 3.30 378 166 * 
CDV = critical difference value; RBC SOD = red blood cell superoxide dismutase; RBC GSH = red blood cell glutathione; FORT = free radical oxygen test; 302 
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Figure legends  308 
 309 
Figure 1. Lactate and heart rate responses to sub-maximal and maximal rowing 310 
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